Please wait. Loading...
 
phases of your business pharmaceutical development.

About “ Global Development ”

Global Development is focused on licensing in and out, of novel generic products.

Global Development is specialized on developing the data for the registration dossiers in patent-free countries with selected partners and also for developing registration dossiers for niche products with European partners.

The Global Development team consists of highly skilled and dedicated professionals, with a wide range of academic competence and solid experience in global generic market as well as of interacting with the various regulatory authorities worldwide

The company covers the full range from single-center to multi-national projects, offering professional Management and services for International - National pharmaceutical companies.

At Global Development, we are highly aware of our clients need to cut timelines and be cost-effective when bringing an  investigational product up for registration. We execute and support the registration procedures in all worldwide countries, with experienced native-speaking experts handling all regulatory and ethical submissions, as well as we provide local monitoring services and support on-site. This together with an excellent network of local investigators will speed up the regulatory processes, as well as facilitating communication.

We are proud that many well-known pharmaceutical companies are placing their trust in us. Their trust is earned due to our expert services. Together with our clients we always think one step ahead to develop innovative concepts and solutions

Learn more about Global Developmet


European Observatory on the price of medicines

The European Observatory allows an overall price observation in European markets. The prices of medicines vary markedly among the European pharma markets, so pharmaceutical companies need to be aware of European price differentials.

The economic recession and the demographic problem, which has serious implications for the sustainability of social security schemes, forced the European countries to take measures to bring down the price of medicines purchased by public health systems, that are now under special stress due and public debt.

In the light of the above, Greece requested the establishment of a European Observatory on the price of medicines.

Eurpean Pharma Prices